Insider Stock Trading History of Kalnik Matthew W.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kalnik Matthew W. since year 2005. The trader's CIK number is 1459477. At the time of this reporting, Kalnik Matthew W. is the SVP Strategic Plan. of Nabi Biopharmaceuticals . (stock ticker symbol NABI). See this page for all insider trading activities at Nabi Biopharmaceuticals .


Stock purchases, sales, and option exercises reported by insider Kalnik Matthew W. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-04-01 NABI Nabi Biopharmaceuticals Sale 6,300 5.80 36,527
2010-07-26 NABI Nabi Biopharmaceuticals Sale 1,500 5.78 8,670
2010-07-19 NABI Nabi Biopharmaceuticals Sale 1,625 5.48 8,905
2010-04-13 NABI Nabi Biopharmaceuticals Sale 2,250 5.78 13,005
2010-04-01 NABI Nabi Biopharmaceuticals Sale 1,950 5.48 10,691
2010-03-17 NABI Nabi Biopharmaceuticals Sale 9,873 5.93 58,546
2010-03-11 NABI Nabi Biopharmaceuticals Option Ex 1,125 3.95 4,443
2010-03-11 NABI Nabi Biopharmaceuticals Sale 1,125 5.95 6,693
2010-03-02 NABI Nabi Biopharmaceuticals Option Ex 2,250 3.95 8,887
2010-03-02 NABI Nabi Biopharmaceuticals Sale 2,250 5.45 12,262
2009-11-16 NABI Nabi Biopharmaceuticals Sale 7,674 4.47 34,333
2009-11-17 NABI Nabi Biopharmaceuticals Sale 6,900 4.97 34,299

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kalnik Matthew W. (SVP Strategic Plan. of Nabi Biopharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.